article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent between the forecast period: 2023 and 2028. Having been valued at $27.04

article thumbnail

Rising Demand for Pharmaceutical Secondary Packaging Providers

Roots Analysis

In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023. 3] Some of the advantages offered by pharmaceutical secondary packaging have been depicted below.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Janssen rebrands its identity

European Pharmaceutical Review

The Janssen Pharmaceutical Companies of Johnson & Johnson has changed its name to Johnson & Johnson Innovative Medicine (J&J Innovative Medicine). This new re-brand for the company follows the appointment its new Executive Vice President, Pharmaceuticals, R&D, an ex- Sanofi executive, in February 2023.

article thumbnail

European Commission authorises one of first ustekinumab biosimilars in Europe

European Pharmaceutical Review

“approval [of Pyzchiva ® (biosimilar ustekinumab)] of is a crucial step towards offering European patients an additional safe and effective treatment option” Pharmaceutical company Sandoz has announced that the European Commission (EC) has granted marketing authorisation for Pyzchiva ® (biosimilar ustekinumab ).

article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. 43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for Pharmaceutical Manufacturing.

article thumbnail

Construction starts on $400m biosimilars production centre in Slovenia

European Pharmaceutical Review

Sandoz announced plans for the facility in March 2023. Once completed, the 40,000-square-metre centre will be used to produce active pharmaceutical ingredients (API) for biosimilars in Sandoz’s rheumatology, oncology and immunology portfolio. The site employs 775 people full time, Sandoz said.

article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

Additionally, this can be caused by “poor handling, repackaging, and nonadherence to good manufacturing practices [GMP] during dispensing and packaging have resulted in the microbiological contamination of non-sterile pharmaceutical products.” Ahmed et al.